Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

NCT06315231 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

226

Enrollment

OTHER

Sponsor class

Conditions

Post-stroke Cognitive Impairment

Interventions

DRUG: Edaravone dexborneol sublingual tablet
DRUG: Placebo

Sponsor

Simcere Pharmaceutical Co., Ltd